Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Welt, Anja
TRACE, NCT05253911: Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.	Recruiting	N/A	300	Europe	TUKYSA®	iOMEDICO AG, Seagen Inc.	HER2-positive Breast Cancer	05/27	05/27
SMARAGD, NCT05129969: Registry Platform Ovarian and Endometrial Cancer	Recruiting	N/A	1375	Europe	Physician's choice according to patient's needs.	iOMEDICO AG	Ovarian Cancer, Endometrial Cancer, Ovary Neoplasm, Endometrial Neoplasms, Carcinoma, Ovarian, Carcinoma, Neoplasm, Ovarian	12/30	12/30
CATCH, NCT05652569: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer	Recruiting	N/A	5000	Europe	Genomic Profiling / Sequencing	German Cancer Research Center, University Hospital Heidelberg	Metastatic Breast Cancer	12/30	12/30